
Takeda opens R&D facility in San Diego, California
pharmafile | May 2, 2019 | News story | Manufacturing and Production, Research and Development | CNS, GI, Japan, Takeda, california, neuroscience, san diego
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 staff.
The new facility will be focused on drug discovery in the areas of neuroscience and gastroenterology (GI).
The centre houses research platform groups across structural and computational biology, early target discovery and biologics for the advancement of potential molecules.
Takeda hopes the facility will supplement its R&D centres in Cambridge, Massachusetts and Shonan, Japan.
Takeda Pharmaceutical Research head Steve Hitchcock commented: “Our San Diego research centre demonstrates an ideal balance between highly specialised internal research competencies and dedication to external partnerships both within the local community and on a global scale.”
“By consulting with and leveraging our relationships with academic and industry partners and patient groups, we are able to operate nimbly and efficiently to advance early discovery research that could potentially translate into transformative, life-changing therapies for patients in need, complementing our efforts in our other global research centres in Cambridge and Shonan.”
Louis Goss
Related Content

Von Willebrand disease – increasing awareness and access to vital care
Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

Combination treatments: Takeda’s Implementation Framework and the broader landscape
Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …

Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
Johnson & Johnson has submitted a supplemental New Drug Application to the US Food and …






